Menu
ICPA Health Products Limited, one of the leading manufacturers in the oral healthcare segment, with an international presence in 32 countries, strives to develop innovative healthcare products to support healthcare professionals in disease management and to promote wellness practices among people to help them achieve optimum health and enjoy a good quality of life.
White spot lesions (WSLs) are visible signs of early enamel demineralisation. During fixed orthodontic treatment, brackets complicate plaque removal, increasing the risk of these lesions.
Emerging evidence reinforces the clinical value of triamcinolone acetonide in managing oral lichen planus (OLP), particularly when balancing symptom control against the risk of oral
A 2026 systematic review and meta-analysis involving nearly 30,000 patients provides compelling evidence supporting chlorhexidine over povidone-iodine for preoperative surgical skin antisepsis. Preventing surgical site
A new randomized clinical trial offers encouraging evidence for dentists managing dentin hypersensitivity. A toothpaste containing 5% novel bioactive glass plus 1425 ppm sodium fluoride
A large 2026 study involving nearly 100,000 adults found that people with more comprehensive oral-hygiene habits had a lower risk of ischemic stroke. The finding
Dentists can be reassured by the current evidence: short-term chlorhexidine mouthwash use has not been shown to cause a clinically meaningful increase in blood pressure
